Transmucosal Drug Delivery Devices Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts
Discover trends, market shifts, and competitive outlooks for the transmucosal drug delivery devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#How Has the Transmucosal Drug Delivery Devices Market Growth Performance Trended Historically, And What Lies Ahead?3
There has been a significant expansion in the market size of transmucosal drug delivery devices in recent years. This market is set to balloon from $50.24 billion in 2024 to $55.04 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.6%. The previous growth can be traced back to several factors; the urgency for swift angina relief, the utilization of sublingual delivery for swift absorption into the bloodstream, the aim to evade gastrointestinal degradation, the creation of buccal tablets, and the demand for non-invasive peptide and protein delivery.
The market for transmucosal drug delivery devices is anticipated to witness robust expansion in the following years, surging to a value of $78.21 billion in 2029 with a 9.2% compound annual growth rate (CAGR). The predicted growth during this period can be linked to the progress in sophisticated drug delivery systems, high occurrence of persistent diseases, a trending interest in tailored medicine, an aging demographic requiring more medication, and enhanced consciousness. Key trends noted for the forecast period are the widening in healing uses, modification of drug delivery devices to suit personalized medicine, endorsements and directives from regulatory bodies, emerging markets, environment-friendly devices, and innovative concoctions.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16812&type=smp
Which Primay Drivers Are Accelerating Growth in the Transmucosal Drug Delivery Devices Market?
The upward trend in chronic illnesses is predicted to fuel the transmucosal drug delivery devices market’s expansion. Chronic illnesses, which normally develop gradually and persist, necessitate continuous medical intervention to curb symptoms and stave off complications. Rising lifestyle-related issues, an aging populace, environmental influences, healthcare system issues, and urbanization contribute to an increase in chronic illnesses. Transmucosal drug delivery devices are utilized for these enduring diseases, offering controlled and effective medication delivery, maintaining consistent therapeutic levels, and enhancing patient compliance. For instance, a report released by the Leukemia & Lymphoma Society (LLS), a charity organization in the US, stated that in August 2023, someone gets diagnosed with Leukemia, Lymphoma, or Myeloma every three minutes in the US. In 2023, about 184,720 individuals are anticipated to receive these diagnoses, accounting for 9.4% of the projected 1,958,310 new cancer cases for that year. Consequently, the escalating prevalence of chronic diseases is stimulating the growth of the transmucosal drug delivery devices market.
What Segment Types Define the Transmucosal Drug Delivery Devices Market Structure?
The transmucosal drug delivery devices market covered in this report is segmented –
1) By Type: Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery
2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types
3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications
4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals
Subsegments:
1) By Passive Transdermal Drug Delivery: Reservoir Systems, Matrix Systems, Micro-Needle Systems, Pressure-Sensitive Adhesive Systems
2) By Active Transdermal Drug Delivery: Iontophoresis, Sonophoresis, Electroporation, Thermal Ablation, Microporation
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=16812&type=smp
Which Regions Are Key Players in the Growth of the Transmucosal Drug Delivery Devices Market?
North America was the largest region in the transmucosal drug delivery devices market in 2024. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing the Transmucosal Drug Delivery Devices Industry Evolution?
Leading firms in the transmucosal drug delivery device sector are focusing on the creation of novel smart platforms, such as unique transdermal patch delivery systems, to increase drug absorption and augment patient convenience and compliance. These unique transdermal patch delivery platforms represent specific technologies that companies own to facilitate the administration of medicines via the skin, guarantee a controlled release, and improve therapeutic results. For instance, Starton Therapeutics Inc., a biotech company from the US, introduced STARSILON in January 2024 – a distinctive proprietary transdermal patch delivery platform, designed for long-term therapeutic administration of difficult-to-formulate active pharmaceutical ingredients (APIs). This development widens the scope of transdermal drug delivery possibilities for complex APIs, augmenting therapeutic potency by offering sustained delivery rates.
View the full report here:
What Is the Definition of the Transmucosal Drug Delivery Devices Market?
Transmucosal drug delivery devices are medical devices designed to deliver drugs through the mucous membranes, such as those in the mouth, nose, or rectum, for rapid absorption into the bloodstream. These devices are used to administer medications that are poorly absorbed by the gastrointestinal tract or that require quick onset of action, such as pain relief or hormone therapy. Their purpose is to bypass the digestive system, providing a more direct and efficient route for drug delivery.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16812
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
